Austar Lifesciences Limited AULSF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.87M | 30.40M | 32.51M | 31.94M | 23.13M |
| Total Receivables | 148.81M | 146.55M | 141.82M | 139.33M | 138.12M |
| Inventory | 42.48M | 41.83M | 39.98M | 39.28M | 31.98M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.23M | 16.96M | 16.40M | 16.12M | 16.03M |
| Total Current Assets | 239.38M | 235.75M | 230.71M | 226.67M | 209.25M |
|
|
|||||
| Total Current Assets | 239.38M | 235.75M | 230.71M | 226.67M | 209.25M |
| Net Property, Plant & Equipment | 58.16M | 57.28M | 56.16M | 55.18M | 56.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.50M | 5.41M | 5.77M | 5.67M | 5.42M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.84M | 1.82M | 2.07M | 2.04M | 2.46M |
| Total Assets | 314.99M | 310.22M | 304.24M | 298.91M | 283.14M |
|
|
|||||
| Total Accounts Payable | 79.53M | 78.33M | 65.82M | 64.66M | 57.52M |
| Total Accrued Expenses | 13.18M | 12.98M | 12.51M | 12.29M | 11.39M |
| Short-term Debt | 22.16M | 21.82M | 33.97M | 33.38M | 28.76M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.72M | 7.61M | 4.66M | 4.58M | 10.44M |
| Total Finance Division Other Current Liabilities | 53.84M | 53.02M | 52.91M | 51.98M | 44.89M |
| Total Other Current Liabilities | 53.84M | 53.02M | 52.91M | 51.98M | 44.89M |
| Total Current Liabilities | 176.43M | 173.75M | 169.86M | 166.88M | 153.00M |
|
|
|||||
| Total Current Liabilities | 176.43M | 173.75M | 169.86M | 166.88M | 153.00M |
| Long-Term Debt | 8.42M | 8.29M | 9.04M | 8.88M | 8.60M |
| Short-term Debt | 22.16M | 21.82M | 33.97M | 33.38M | 28.76M |
| Capital Leases | 1.19M | 1.18M | 1.47M | 1.44M | 2.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.28M | 6.18M | 6.06M | 5.95M | 6.37M |
| Total Liabilities | 192.32M | 189.40M | 186.42M | 183.16M | 170.02M |
|
|
|||||
| Common Stock & APIC | 51.05M | 50.27M | 49.57M | 48.71M | 47.97M |
| Retained Earnings | 65.31M | 64.32M | 62.22M | 61.13M | 59.52M |
| Treasury Stock & Other | 6.03M | 5.94M | 5.81M | 5.71M | 5.49M |
| Total Common Equity | 122.39M | 120.54M | 117.60M | 115.54M | 112.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 122.39M | 120.54M | 117.60M | 115.54M | 112.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 284.90K | 280.50K | 220.20K | 216.30K | 141.70K |
| Total Equity | 122.68M | 120.82M | 117.82M | 115.76M | 113.12M |
|
|
|||||